Efecto de la edad y el género sobre las consecuencias clínicas y económicas del tratamiento con especialidad farmacéutica de marca o genérica en pacientes con dolor neuropático periférico en práctica clínica habitual-Reference-Cited by-同舟云学术

Efecto de la edad y el género sobre las consecuencias clínicas y económicas del tratamiento con especialidad farmacéutica de marca o genérica en pacientes con dolor neuropático periférico en práctica clínica habitual

Published:2018-04 Issue:3 Volume:33 Page:141-153
ISSN:0213-4853
Container-title:Neurología
language:es
Short-container-title:Neurología

Author:

Navarro-Artieda R.,Rejas-Gutiérrez J.,Pérez-Paramo M.,Sicras-Mainar A.

Publisher

Elsevier BV

Subject

Clinical Neurology

Reference35 articles.

1. International Association for the Study of Pain Neuropathic Pain Special Interest Group. Interventional management of neuropathic pain: NeuPSIG recommendations;Dworkin;Pain.,2013

2. Epidemiology of neuropathic pain and its impact on quality of life;Smith;Curr Pain Headache Rep.,2012

3. Modeling the predictive value of pain intensity on costs and resources utilization in patients with peripheral neuropathic pain;Pérez;Clin J Pain.,2015

4. Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: A review;Barrett;Pain Med.,2007

5. Prevalence, causes, and treatment of neuropathic pain in Dutch nursing home residents: A retrospective chart review;Van Kollenburg;J Am Geriatr Soc.,2012

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of Brand-Name and Generic Versions of Glimepiride for Diabetes Mellitus Care: Experience at a Medical Center in Taiwan;INT J GERONTOL;2019

2. Switching medication products during the treatment of psychiatric illness;International Journal of Psychiatry in Clinical Practice;2019-01-02

3. Treatment persistence and adherence and their consequences on patient outcomes of generic versus brand-name statins routinely used to treat high cholesterol levels in Spain: a retrospective cost-consequences analysis;Lipids in Health and Disease;2018-12

4. Consequences on economic outcomes of generic versus brand-name drugs used in routine clinical practice: the case of treating peripheral neuropathic pain or generalized anxiety disorder with pregabalin;Expert Review of Pharmacoeconomics & Outcomes Research;2018-09-17

5. Cost of treating peripheral neuropathic pain with pregabalin or gabapentin at therapeutic doses in routine practice;Journal of Comparative Effectiveness Research;2018-07